Include: 16 videos + 1 pdf, size: 9.54 GB
+ Target Audience: neurologists, neurosurgeons, advanced practice providers, neurocritical care clinicians
+ Information:
There have been significant advances in the diagnosis and treatment of many neurological diseases. Attempts to cover these scientific advances have been made through peer-reviewed journals, national and international society meetings, and consensus statements. This program will emphasize evidence-based strategy for the current treatment of neurological disorders and cutting-edge research in novel therapeutics.
Target Audience
This conference is designed for physicians, nurses, nurse practitioners, physician assistants, physical therapists, occupational therapists, speech-language therapists and residents/fellows in the neurological sciences will benefit from this course.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Apply new medical and surgical therapies for the treatment of neurological diseases
- Discuss new and future therapies for stroke, epilepsy, demyelinating diseases, headaches, Parkinson’s disease, and neuromuscular diseases
- Describe the diagnosis and treatment of dementias, vestibular dysfunction, stroke, and complex headache presentations
The Houston Methodist 18th Annual Advances in Neurology Symposium 2025 is best for neurologists, neurosurgeons, advanced practice providers, neurocritical care clinicians, allied health professionals, and researchers who need concise, evidence‑based updates on diagnosis, medical and surgical therapies, and emerging therapeutics in neurology.
Who should attend
- Neurologists and neurosurgeons seeking practice‑changing updates and surgical indications.
- Neurocritical care physicians and intensivists focused on acute neurological emergencies.
- Advanced practice providers (NPs, PAs), nurses, and therapists working in neurology and stroke services.
- Clinical researchers and trainees wanting exposure to cutting‑edge translational work.
- Hospital leaders and program directors aiming to align local practice with current evidence.
+ Topics:
| 18th Annual Advances in Neurology Symposium | ||
| September 12 – 13, 2025 | ||
| Friday, September 12, 2025 | ||
| Time | Topic | Speaker(s) |
| 7:00 AM | Registration and Breakfast | |
| 8:00 AM | Welcome and Introductions | Rajan R. Gadhia, MD |
| Eugene C. Lai, MD, PhD | ||
| 8:05 AM | Innovations and Advances in Diagnostics and Therapeutics of Inherited Peripheral Neuropathies | Jun Li, MD, PhD, FANA, FAAN |
| 8:55 AM | Question and Answer Discussion | |
| 9:00 AM | Innovations and Advances in Cell-Based Therapies for Motor Neuron Disease | Stanley H. Appel, MD |
| 9:50 AM | Question and Answer Discussion | |
| 9:55 AM | Break and Exhibits | |
| 10:15 AM | Innovations and Advances in Diagnostics and Therapeutics of Neuromuscular Junction Disorders | Bing Liao, MD, PhD |
| 11:05 AM | Question and Answer Discussion | |
| 11:10 AM | Innovations and Advances in Management of Cephalgia | Julia Jones, MD |
| 12:00 PM | Question and Answer Discussion | |
| 12:05 PM | Lunch and Exhibits | |
| 1:05 PM | Announcements and Introductions | Rajan R. Gadhia, MD |
| Eugene C. Lai, MD, PhD | ||
| 1:10 PM | The expanding use of botulinum toxin in movement disorders and other neurologic conditions | Joseph F. Imbs, DO |
| 2:00 PM | Question and Answer Discussion | |
| 2:05 PM | Dural Fistulas: Same Disease… Multiple Clinical Presentations | Orlando Diaz, MD |
| 2:55 PM | Question and Answer Discussion | |
| 3:00 PM | Break and Exhibits | |
| 3:20 PM | New Hope in Alzheimer’s Treatment in 2025 | Joseph C. Masdeu, MD, PhD |
| 4:10 PM | Question and Answer Discussion | |
| 4:15 PM | Innovations and Advances in Neuro-oncological Treatment of Primary Brain Tumors | Ashley E. Aaroe, MD |
| 5:05 PM | Question and Answer Discussion | |
| 5:10 PM | Adjournment | |
| Saturday, September 13, 2025 | ||
| Time | Topic | Speaker(s) |
| 7:00 AM | Registration and Breakfast | |
| 8:00 AM | Welcome and Introductions | Rajan R. Gadhia, MD |
| Eugene C. Lai, MD, PhD | ||
| 8:05 AM | Advances in Diagnostic Criteria of MS and Demyelinating Syndromes | Abdul R. Alchaki, MD |
| 8:55 AM | Question and Answer Discussion | |
| 9:00 AM | Innovations and Advances in Medical Management of Epilepsy | Rohit Kuruvilla, MD |
| 9:50 AM | Question and Answer Discussion | |
| 9:55 AM | Break and Exhibits | |
| 10:15 AM | Innovative Advances in Surgical Diagnosis and IOM | Amit Verma, MD |
| 11:05 AM | Question and Answer Discussion | |
| 11:10 AM | AI and novel imaging in Acute Stroke | John Volpi, MD |
| 12:00 PM | Question and Answer Discussion | |
| 12:05 PM | Lunch and Exhibits | |
| 1:05 PM | Announcements and Introductions | Rajan R. Gadhia, MD |
| Eugene C. Lai, MD, PhD | ||
| 1:10 PM | Presentation, Diagnosis and Management of Stroke in the Young | Tanu Garg, MD |
| 2:00 PM | Question and Answer Discussion | |
| 2:05 PM | Novel Tools and Updates in Concussion Diagnosis and Management | Kenneth Podell, PhD, FACPN |
| 2:55 PM | Question and Answer Discussion | |
| 3:00 PM | Break and Exhibits | |
| 3:20 PM | Innovations and Advances in Diagnosis and Interventional/Surgical Management of Parkinson’s Disease | Andrew Billnitzer, MD |
| 4:10 PM | Question and Answer Discussion | |
| 4:15 PM | Five Medicines That Can Blind Your Patient and Blind Side You | Andrew Lee, MD |
| 5:05 PM | Question and Answer Discussion | |
| 5:10 PM | Adjournment | |



